Philip Tom

President & Chief Financial Officer at Avertix Medical

Executive Vice President & Chief Financial Officer
2023 - Current
Avertix is a cutting-edge medical device company offering the first and only FDA-approved Class III implantable device that can detect silent and atypical symptomatic heart attacks in real-time. With a robust portfolio of U.S. patents pertaining to Acute Coronary Syndrome (ACS) events, Avertix is at the forefront of innovation in cardiovascular care and is committed to improving patient outcomes and saving lives through advanced medical technologies. For more information, visit avertix.com.

Investment Team
2014 - 2018
Buyouts and majority recapitalizations in both high-growth and mature software businesses